Lunai Bioworks Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM
Lunai Bioworks Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | 181.45K | 181.45K | 181.45K | 181.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 187.19K | 185.53K | 186.58K | 181.45K | 118.74K | 116.67K | 112.36K | 85.09K | 85.42K | 158.97K | 231.29K | 331.68K | 303.35K | 201.55K | 100.39K |
Gross Profit | -5.74K | -4.07K | -5.12K | n/a | -118.74K | -116.67K | -112.36K | -85.09K | -85.42K | -158.97K | -231.29K | -331.68K | -303.35K | -201.55K | -100.39K |
Operating Income | -79.15M | -92.18M | -91.9M | -47.45M | -53.28M | -40.15M | -40.25M | -38.56M | -20.58M | -20.55M | -22.51M | -22.83M | -32.05M | -31.07M | -28.05M |
Interest Income | 126.6K | 126.6K | 142.54K | 24.31K | 24.31K | 24.31K | 11.38K | 8.63K | 107.79K | 115.08K | 120.55K | 122.04K | 27.26K | 21.4K | 15.98K |
Pretax Income | -67.01M | -84.22M | -81.5M | -46.46M | -53.93M | -41.23M | -41.16M | -39.68M | -106.72M | -108.6M | -110.72M | -113.43M | -40.56M | -38.39M | -34.74M |
Net Income | -67.01M | -84.22M | -81.5M | -46.46M | -53.93M | -41.23M | -41.16M | -39.68M | -106.72M | -108.6M | -110.72M | -113.43M | -40.56M | -38.39M | -34.74M |
Selling & General & Admin | 18.88M | 22.31M | 21.57M | 24.56M | 22.51M | 18.65M | 19.05M | 15.32M | 15.53M | 14.45M | 14.52M | 14.36M | 13.28M | 12.47M | 10.32M |
Research & Development | 1.08M | 2.07M | 2.53M | 2.71M | 3.27M | 2.42M | 2.13M | 4.17M | 4.94M | 5.91M | 7.73M | 8.13M | 18.44M | 18.34M | 17.53M |
Other Expenses | 93.38M | 93.54M | 93.51M | 45.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 31.49K | 62.32K | 93.08K |
Operating Expenses | 113.34M | 117.95M | 117.67M | 73.22M | 25.9M | 21.19M | 21.26M | 19.99M | 20.94M | 20.81M | 22.7M | 22.49M | 31.75M | 30.87M | 27.95M |
Interest Expense | 816.08K | 947.54K | 1.11M | 1.04M | 1.04M | 981.38K | 799.28K | 715.6K | 547.85K | 378.2K | 378.69K | 372.84K | 375.85K | 376.99K | 377.03K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | 43.42K | 87.35K | 87.35K | 87.35K | 43.93K | n/a | n/a | n/a | n/a |
Cost & Expenses | 113.34M | 117.95M | 117.67M | 73.22M | 25.9M | 21.19M | 21.29M | 20.02M | 21M | 20.97M | 22.93M | 22.83M | 32.05M | 31.07M | 28.05M |
Income Tax Expense | n/a | 320.07K | 336.01K | 336.01K | 336.01K | 15.94K | -4 | -4 | -6 | -1 | 3.00 | 37.00 | -436 | -1.29K | -2.45K |
Shares Outstanding (Basic) | 162.33M | 161.83M | 156.57M | 96.25M | 107.48M | 65.85M | 64.48M | 63.7M | 55.97M | 55.51M | 55.1M | 53.01M | 52.64M | 52.32M | 52.22M |
Shares Outstanding (Diluted) | 163.93M | 161.83M | 156.57M | 96.25M | 107.48M | 65.85M | 64.48M | 63.7M | 55.97M | 55.51M | 55.1M | 53.01M | 52.64M | 52.32M | 52.22M |
EPS (Basic) | -0.48 | -0.64 | -0.67 | -0.53 | -0.73 | -0.65 | -0.66 | -0.66 | -2 | -2.04 | -2.09 | -2.15 | -0.82 | -0.79 | -0.72 |
EPS (Diluted) | -0.48 | -0.64 | -0.67 | -0.53 | -0.73 | -0.65 | -0.66 | -0.66 | -2 | -2.04 | -2.09 | -2.15 | -0.82 | -0.79 | -0.72 |
EBITDA | -102.83M | -154.12M | -151.22M | -116.26M | -86.97M | -40.13M | -40.24M | -38.85M | -106.06M | -108.03M | -110.08M | -112.73M | -39.78M | -37.61M | -33.97M |
EBIT | -98.97M | -150.24M | -147.36M | -112.39M | -87.08M | -40.25M | -40.36M | -38.97M | -106.17M | -108.22M | -110.34M | -113.06M | -40.18M | -38.01M | -34.36M |
Depreciation & Amortization | 127.6K | 125.93K | 126.98K | 121.86K | 118.74K | 116.67K | 112.36K | 113.5K | 113.82K | 187.37K | 259.69K | 331.68K | 602.72K | 531.75K | 461.35K |